Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trichothecenes | 1 | 2003 | 7 | 0.210 |
Why?
|
| Fusarium | 1 | 2003 | 11 | 0.210 |
Why?
|
| Echinacea | 1 | 2002 | 1 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 25 | 0.200 |
Why?
|
| Phytotherapy | 1 | 2002 | 23 | 0.200 |
Why?
|
| Plant Extracts | 1 | 2002 | 61 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 109 | 0.190 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2005 | 176 | 0.070 |
Why?
|
| Laccase | 1 | 2005 | 2 | 0.070 |
Why?
|
| Porifera | 1 | 2005 | 9 | 0.070 |
Why?
|
| Sesquiterpenes | 1 | 2005 | 22 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2003 | 128 | 0.060 |
Why?
|
| Chromatography, Thin Layer | 1 | 2003 | 18 | 0.050 |
Why?
|
| Crystallization | 1 | 2003 | 47 | 0.050 |
Why?
|
| Culture Media | 1 | 2003 | 96 | 0.050 |
Why?
|
| Carcinogens, Environmental | 1 | 2002 | 2 | 0.050 |
Why?
|
| Oryza | 1 | 2003 | 37 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 73 | 0.050 |
Why?
|
| Zea mays | 1 | 2002 | 8 | 0.050 |
Why?
|
| Fumonisins | 1 | 2002 | 4 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2002 | 17 | 0.050 |
Why?
|
| Sulfones | 1 | 2002 | 7 | 0.050 |
Why?
|
| Lethal Dose 50 | 1 | 2002 | 13 | 0.050 |
Why?
|
| Celecoxib | 1 | 2002 | 9 | 0.050 |
Why?
|
| Cyclooxygenase 1 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Aedes | 1 | 2002 | 5 | 0.050 |
Why?
|
| Lactones | 1 | 2002 | 7 | 0.050 |
Why?
|
| Naproxen | 1 | 2002 | 11 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 18 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 22 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2002 | 17 | 0.050 |
Why?
|
| Amides | 1 | 2002 | 18 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 86 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 68 | 0.050 |
Why?
|
| Plant Roots | 1 | 2002 | 46 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2002 | 62 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2002 | 68 | 0.050 |
Why?
|
| Aspirin | 1 | 2002 | 119 | 0.050 |
Why?
|
| Glucose | 1 | 2002 | 191 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 587 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 71 | 0.030 |
Why?
|
| Animals | 2 | 2005 | 9932 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2005 | 16 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2005 | 45 | 0.020 |
Why?
|
| Dimerization | 1 | 2005 | 75 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2005 | 66 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2005 | 101 | 0.020 |
Why?
|
| Catalysis | 1 | 2005 | 133 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 200 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 214 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2005 | 441 | 0.010 |
Why?
|
| Maillard Reaction | 1 | 2002 | 1 | 0.010 |
Why?
|
| Mycotoxins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 762 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2002 | 86 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2002 | 84 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1258 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 186 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 538 | 0.010 |
Why?
|
| Humans | 1 | 2005 | 26777 | 0.000 |
Why?
|